The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review

• मुख्य लेखकों: Ludivine Boudieu (लेखक), Myriam Mennetrier (लेखक), Pierre-Michel Llorca (लेखक), Ludovic Samalin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Ketamine and its enantiomers represent an innovative glutamatergic agent as a treatment for individuals with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation and behavior. Intranasal (IN) formulations could allow for quick onset of action on depressive...